Document is current
Any future updates will be listed below
-
Authors
Kirii, Yosuke
Ishiyama, Masaki
Sato, Kei
Takasaki, Akihiro
Omori, Taku
Sugiura, Emiyo
Fujimoto, Naoki
Kurita, Tairo
Dohi, Kaoru
-
Funding
Funding for this research was provided by:
Abbott Japan
Zeon
Otsuka Pharmaceutical
Mochida Pharmaceutical Company
Daiichi Sankyo Company
Bayer Yakuhin
Astrazeneca PLC
Boehringer Ingelheim Japan
Novartis Pharma K.K
- License Information
-
More Information
Article History
Received: 31 May 2025
Accepted: 8 September 2025
First Online: 22 September 2025
Declarations
:
: The authors have no relationships to disclose that are relevant to the contents of this manuscript. Kaoru Dohi received departmental research grant support from Zeon medical Inc., Otsuka Pharmaceutical Co., Ltd, Abbott Medical Japan LLC, and Mochida Pharmaceutical Co., Ltd. Kaoru Dohi also received a speaker fee from Daiichi Sankyo Company Limited, Bayer Yakuhin, Ltd, AstraZeneca PLC, Otsuka Pharmaceutical Co., Nippon Boehringer Ingelheim Co., Novartis Pharma K.K and Abbott Medical Japan LLC. Other authors have no financial conflicts of interest to disclose.
